402822-41-7

Upstream product

• 202120-61-4 (S)-2-((S)-2-Dibenzylamino-3-hydroxy-propionylamino)-4-methyl-pentanoic acid [(R)-2-(4-fluoro-3-nitro-phenyl)-2-hydroxy-ethyl]-amide 
• 221004-71-3 (S)-2-Amino-4-methyl-pentanoic acid [(R)-2-(4-fluoro-3-nitro-phenyl)-2-hydroxy-ethyl]-amide 
• 202120-59-0 Acetic acid (R)-2-acetylamino-1-(4-fluoro-3-nitro-phenyl)-ethyl ester 
• 313055-06-0 (R)-2-Amino-1-(4-fluoro-3-nitro-phenyl)-ethanol 
• 13139-15-6 N-tert-butoxycarbonyl-L-leucine 
• 202120-60-3 {(S)-1-[(R)-2-(4-Fluoro-3-nitro-phenyl)-2-hydroxy-ethylcarbamoyl]-3-methyl-butyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

A convergent approach to cyclopeptide alkaloids: Total synthesis of sanjoinine G1

A general strategy for the synthesis of cyclopeptide alkaloids containing an endocyclic aryl-alkyl ether bond has been developed featuring a key intramolecular SNAr reaction. The importance of the N-terminal protective group in the realization

Approach towards the total synthesis of cyclopeptide alkaloids

Macrocylization via formation of aryl-alkyl ether bond was a key step in a model synthesis of 14-membered cyclopeptide alkaloids. A new chemoenzymatic synthesis of chiral 2-amino-1-arylethanol was developed in the course of this study.